ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CAR T-cell therapy bb2121 shows promising efficacy for multiple myeloma – Healio

CAR T-cell therapy bb2121 shows promising efficacy for multiple myelomaHealio“BCMA is a member of the TNF receptor superfamily and is express universally on multiple myeloma cells. Critically, expression is restricted to plasma cells and only a very sm… Continue reading

2017-12-13 Michael Zand NEWS

British Council allocates 1.5m pound fund to joint Israeli stem cell research – The Jerusalem Post

The Jerusalem PostBritish Council allocates 1.5m pound fund to joint Israeli stem cell researchThe Jerusalem PostUK and Israeli research institutions will work together on four new, three-year bilateral projects in the use of stem cells to tackle degen… Continue reading

2017-12-13 Michael Zand NEWS

British Council allocates 1.5m pound fund to joint Israeli stem cell research – The Jerusalem Post

The Jerusalem PostBritish Council allocates 1.5m pound fund to joint Israeli stem cell researchThe Jerusalem PostUK and Israeli research institutions will work together on four new, three-year bilateral projects in the use of stem cells to tackle degen… Continue reading

2017-12-13 Michael Zand NEWS

Omalizumab improves efficacy of oral immunotherapy for multiple … – Pharmacy Today, American Pharmacists Association, pharmacist.com

MedscapeOmalizumab improves efficacy of oral immunotherapy for multiple …Pharmacy Today, American Pharmacists Association, pharmacist.comCombining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves th… Continue reading

2017-12-13 Michael Zand NEWS

CRISPR gene editing moved into humans in 2017 – Science News

Continue reading

2017-12-13 Michael Zand NEWS

Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017 – Science News


Chemical & Engineering News

CRISPR gene editing moved into humans in 2017
Science News
Whether scientists should use CRISPR/Cas9’s power to create gene-edited babies is a matter of heated debate. Until March, the battles were mostly academic because previous attempts to edit human embryos were done in embryos that would never develop …
If CRISPR is so amazing, why can’t we edit human genes yet … – ABCABC Online
CRISPR gene editing is coming to the clinicChemical & Engineering News
Genetic Differences Could Impact Efficacy and Safety of CRISPRGenetic Engineering & Biotechnology News
Nature.com –EurekAlert (press release)
all 38 news articles »
Continue reading

2017-12-13 Michael Zand NEWS

Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017 – Science News


Science News

Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017
Science News
The U.S. Food and Drug Administration approved two personalized treatments that engineer a patient’s own immune system to hunt down and kill cancer cells. The treatments, the first gene therapies ever approved by the FDA, work in people with certain …

Continue reading

2017-12-13 Michael Zand NEWS

CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018 – Labiotech.eu (blog)

Labiotech.eu (blog)CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018Labiotech.eu (blog)CRISPR Therapeutics and Vertex Pharmaceuticals are taking action to start a first clinical trial with CRISPR/Cas9 in Europe in 2018. The … Continue reading

2017-12-13 Michael Zand NEWS
  • 1
  • …
  • 788
  • 789
  • 790
  • 791
  • 792
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Science News

Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017
Science News
The U.S. Food and Drug Administration approved two personalized treatments that engineer a patient’s own immune system to hunt down and kill cancer cells. The treatments, the first gene therapies ever approved by the FDA, work in people with certain …